Carsten Utoft Niemann

88PUBLICATIONS
285CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsSocial epidemiologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (88)

|Oct 02, 2026
First-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival.

|Sep 18, 2026
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax.

|Aug 27, 2026
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

|Aug 14, 2026
Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi-Country Needs Assessment.

|Jul 28, 2026
The Danish Lymphoid Cancer Research (DALY-CARE): Genetic Cohort Profile.

|Apr 27, 2026
Sex differences in cancer incidence and survival: a Danish nationwide population-based study assessing 35 cancer sites.

Pageof 15

Frequent Collaborators

30 joint publications

Christian Brieghel

14 joint publications

Arnon P Kater

11 joint publications

Caspar da Cunha-Bang

11 joint publications

Moritz Fürstenau